PharmTech spoke with Dr. Asma Patel, VP Global Commercial and Scientific Consulting–Drug Product, to find out how the growth ...

Agno Pharma, a global contract development and manufacturing organization (CDMO) specializing in small-molecule active ...

Market valued at $72.4M in 2024, projected 7.30% CAGR growth driven by pharmaceutical API synthesis, food-grade ...

Proposal aims to build a database of bulk drug traders, improve traceability of imported raw materials, over 70% of which ...

In the fast-paced world of drug development, time is often the most precious commodity. For biotech companies working on oral ...

A CDMO championing a commitment to patients may sound like lip service or branding, but truly patient-centric CDMOs offer ...

TRS offers a robust solution for analyzing heterogeneous samples, providing comprehensive spectral data essential for ...

The move would dismantle the existing system under which bulk drugs and finished formulations operate under a common licence ...

Key market opportunities for the global small molecule healthcare contract manufacturing sector include increased demand for ...

In the regulated pharmaceutical sector, maintaining awareness and connectivity is vital. Industry professionals attend ...

Mandara Biopharma Inc., a privately held U.S.-based biopharmaceutical company focused on novel therapies for central nervous system (CNS) disorders, today announced that it has filed an ...

AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...